Does INSULIN ASPART Cause Stent placement? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Stent placement have been filed in association with INSULIN ASPART (NovoLog Mix 70/30). This represents 0.1% of all adverse event reports for INSULIN ASPART.
31
Reports of Stent placement with INSULIN ASPART
0.1%
of all INSULIN ASPART reports
0
Deaths
19
Hospitalizations
How Dangerous Is Stent placement From INSULIN ASPART?
Of the 31 reports, 19 (61.3%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN ASPART. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN ASPART Cause?
Blood glucose increased (4,743)
Hypoglycaemia (1,647)
Blood glucose decreased (1,421)
Diabetic ketoacidosis (1,398)
Drug ineffective (1,243)
Product quality issue (1,049)
Dyspnoea (746)
Vomiting (727)
Malaise (706)
Nausea (694)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which INSULIN ASPART Alternatives Have Lower Stent placement Risk?
INSULIN ASPART vs INSULIN ASPART\INSULIN DEGLUDEC
INSULIN ASPART vs INSULIN BEEF
INSULIN ASPART vs INSULIN DEGLUDEC
INSULIN ASPART vs INSULIN DEGLUDEC\LIRAGLUTIDE
INSULIN ASPART vs INSULIN DETEMIR